Category Archives: Policy

Bush v Kilgore v the Old Order v Now

In 2005, Nicholas Steneck at the University of Michigan taught a course in the history of science–“Science, Technology and Society–1940 to the Present.” Here’s his lecture outline for the part about federally funded science and engineering during World War 2: … Continue reading

Posted in Policy, Sponsored Research, Vannever Bush | Tagged , , , | Comments Off on Bush v Kilgore v the Old Order v Now

Inventor freedom and the unexpected model of innovation, 1

Consider an alternative to the present university administrator mania for patenting. Let’s start with inventor freedom and then look once more at what I call Vannevar Bush’s unexpected model of innovation. There are difficulties in the effort. First, the social … Continue reading

Posted in Bayh-Dole, Bozonet, Innovation, Policy | Tagged , , , , | Comments Off on Inventor freedom and the unexpected model of innovation, 1

Peace measures

In 1917, in the United States, six million people suffered from syphilis. The only drug that offered some relief at the time was an arsenic compound made in Germany called salvarsan. The United States entered the first world war against … Continue reading

Posted in History, Policy | Tagged , , | Comments Off on Peace measures

A century of reaping enormous profits at the expense of sickness and misfortune, 3

The Mayo doctors, having made their specific arguments with regard to salvarsan in their 1917 letter to Congress, end with a full scale plea, not only to cancel the patent for salvarsan but also for other German drugs, and for … Continue reading

Posted in Bayh-Dole, History, Policy | Tagged , , , | Comments Off on A century of reaping enormous profits at the expense of sickness and misfortune, 3

A century of reaping enormous profits at the expense of sickness and misfortune, 2

Mayo’s research publication Discovery’s Edge recently ran an article on “The Power of Patents.” In the article, Mayo Clinic wonders about patent royalties from a famous past invention: When Mayo Clinic colleagues Edward Kendall, Ph.D., and Philip Hench, M.D., along with … Continue reading

Posted in History, Policy | Tagged , , , | Comments Off on A century of reaping enormous profits at the expense of sickness and misfortune, 2

A century of reaping enormous profits at the expense of sickness and misfortune, 1

In June 1917, the United States had just entered the first world war against Germany, and a German chemical maker through its American subsidiary Farbwerke-Hoechst held U.S. patents on salvarsan, a medicine used to treat syphilis. Along letters written on … Continue reading

Posted in Bayh-Dole, Commons, History, Policy | Tagged , , , | Comments Off on A century of reaping enormous profits at the expense of sickness and misfortune, 1

NIST does not understand the government license in Bayh-Dole

NIST has issued a draft green paper that consolidates all the fake history, pseudo data as fact, misrepresentations of Bayh-Dole, and misconceived proposals all in one convenient place. I can’t hope to catch everything, but let’s take a look at … Continue reading

Posted in Bayh-Dole, Bozonet, History, Policy | Tagged , , , | Comments Off on NIST does not understand the government license in Bayh-Dole

NIST’s “substantially fueled” premise for unleashing innovation

Here is a claim from the opening of a recent NIST report–1234–on “Unleashing American Innovation,” a “draft green paper”: The U.S. innovation system is substantially fueled by the discoveries and inventions arising from federally funded R&D at the Nation’s universities, … Continue reading

Posted in Innovation, Metrics, Policy | Tagged , , , | Comments Off on NIST’s “substantially fueled” premise for unleashing innovation

Nine Points to Consider (with regard to AUTM’s licensing survey), 8-9

We are considering nine points with regard to AUTM’s annual licensing survey. We have got through seven points–not validated and with estimates, duplicate reporting, conflating technology and invention, activity measures giving the illusion of a process at work, no reporting … Continue reading

Posted in Bayh-Dole, Metrics, Policy | Tagged , , , , | Comments Off on Nine Points to Consider (with regard to AUTM’s licensing survey), 8-9

Nine Points to Consider (with regard to AUTM’s licensing survey), 1-7

The Association of University Technology Managers, a front group for university licensing professionals, conducts an annual survey of the universities that its members work for. The survey asks for various metrics regarding inventions, patenting, licensing, startups, and revenue. The survey … Continue reading

Posted in Bayh-Dole, Metrics, Policy | Tagged , , , , | Comments Off on Nine Points to Consider (with regard to AUTM’s licensing survey), 1-7